Physician profile
Bhargab M Dixit
NPI 1427007772
$2,041.34
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $674 · 2020: $263 · 2021: $576 · 2022: $118 · 2023: $158 · 2024: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $377 · Education: $33.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $376.69 |
| Education | $33.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $591.69 | 2019-2024 | |
| Janssen Biotech, INC. | $253.86 | 2019-2023 | Stelara |
| Celgene Corporation | $213.29 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $186.63 | 2019-2024 | Eohilia |
| E.R. Squibb & Sons, L.L.C. | $124.74 | 2021 | |
| Redhill Biopharma INC. | $112.10 | 2021 | |
| Janssen Scientific Affairs, LLC | $111.95 | 2021 | |
| Gilead Sciences, INC. | $109.38 | 2019-2020 | |
| Lilly USA, LLC | $94.50 | 2024 | Omvoh |
| Shire North American Group INC | $52.57 | 2019 | |
| Merck Sharp & Dohme LLC | $50.94 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.24 | 2019-2020 | |
| Fresenius USA Marketing, INC. | $27.82 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $20.00 | 2024 | Iqirvo |
| Ironwood Pharmaceuticals, INC | $18.87 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $14.86 | 2019 | |
| Ardelyx, INC. | $13.90 | 2023 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bhargab Dixit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.